Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07753954
Medical Imaging to Re-evaluate Elacestrant Clinical UsageGE HealthcareNot Yet RecruitingPhase 2
NCT07753954Not Yet Recruiting
Phase 2
Medical Imaging to Re-evaluate Elacestrant Clinical UsageGE Healthcare
NCT07754474
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or ObesityBoehringer IngelheimNot Yet RecruitingPhase 1
NCT07754474Not Yet Recruiting
Phase 1
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerate...Boehringer Ingelheim
NCT07754682
Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell LymphomaAssistance Publique - Hôpitaux de ParisNot Yet RecruitingPhase 3
NCT07754682Not Yet Recruiting
Phase 3
Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in...Assistance Publique - Hôp...
NCT07754890
Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma Phase I/II TrialPeking Union Medical College HospitalRecruitingPhase 1
NCT07754890Recruiting
Phase 1
Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma Phase I/II TrialPeking Union Medical Coll...
NCT07756554
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospital AdmissionAmager HospitalRecruitingNot Applicable
NCT07756554Recruiting
Not Applicable
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospi...Amager Hospital
NCT07754318
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)Medtronic CardiovascularNot Yet RecruitingNot Applicable
NCT07754318Not Yet Recruiting
Not Applicable
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)Medtronic Cardiovascular
NCT07755930
Marsili Syndrome as a Gateway to Novel Analgesic TargetsAalborg UniversityNot Yet RecruitingNot Applicable
NCT07755930Not Yet Recruiting
Not Applicable
Marsili Syndrome as a Gateway to Novel Analgesic TargetsAalborg University
NCT07753863
Use of a Silicone Sensor to Protect Fragile Neonatal Skin in Moderately Preterm Infants Needing Continuous Monitoring: the PRO-NEO-SKIN (Protect Neonatal Skin) Pilot StudyPaolo Manzoni Study GroupNot Yet RecruitingNot Applicable
NCT07753863Not Yet Recruiting
Not Applicable
Use of a Silicone Sensor to Protect Fragile Neonatal Skin in Moderately Preterm...Paolo Manzoni Study Group
NCT07754877
Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combined With Chemical Ablation in the Treatment of Uterine Fibroids: A Prospective, Multicenter StudyPeking University Aerospace Center HospitalNot Yet RecruitingNot Applicable
NCT07754877Not Yet Recruiting
Not Applicable
Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combin...Peking University Aerospa...
NCT07754331
Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/DapagliflozinAstraZenecaNot Yet RecruitingPhase 1
NCT07754331Not Yet Recruiting
Phase 1
Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolera...AstraZeneca
NCT07754669
Priming Using Contrast Training ExerciseThe Jerzy Kukuczka Academy of Physical Education in KatowiceCompletedNot Applicable
NCT07754669Completed
Not Applicable
Priming Using Contrast Training ExerciseThe Jerzy Kukuczka Academ...
NCT07755345
Weighted vs Unweighted Plyometric Conditioning on Vertical Jump Performance in Young Male Soccer PlayersIstanbul Gelisim UniversityCompletedNot Applicable
NCT07755345Completed
Not Applicable
Weighted vs Unweighted Plyometric Conditioning on Vertical Jump Performance in Y...Istanbul Gelisim Universi...
NCT07754955
Comparison of Efficacy and Safety of Speedboat Device and Needle Knife for Colorectal Endoscopic Submucosal Dissection: a Multicenter Randomized StudyMahidol UniversityRecruitingNot Applicable
NCT07754955Recruiting
Not Applicable
Comparison of Efficacy and Safety of Speedboat Device and Needle Knife for Color...Mahidol University
NCT07756008
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot Yet RecruitingPhase 2
NCT07756008Not Yet Recruiting
Phase 2
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without...Sun Yat-Sen Memorial Hosp...
NCT07753928
PENTAGON: MS-Related Disability Worsening and Thalamic Volume LossJung Diagnostics GmbHEnrolling By Invitation
NCT07753928Enrolling By Invitation
—
PENTAGON: MS-Related Disability Worsening and Thalamic Volume LossJung Diagnostics GmbH
NCT07755800
Impact of an Arginine-containing Toothpaste on the Subgingival Microbiota in Patients in Supportive Periodontal CareSukirth M Ganesan, BDS, PhDNot Yet RecruitingNot Applicable
NCT07755800Not Yet Recruiting
Not Applicable
Impact of an Arginine-containing Toothpaste on the Subgingival Microbiota in Pat...Sukirth M Ganesan, BDS, P...
NCT07754279
Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy VolunteersMateria Medica HoldingCompletedPhase 1
NCT07754279Completed
Phase 1
Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy VolunteersMateria Medica Holding
NCT07754994
Medication Self-Management Technology for Older AdultsArizona State UniversityNot Yet RecruitingNot Applicable
NCT07754994Not Yet Recruiting
Not Applicable
Medication Self-Management Technology for Older AdultsArizona State University
NCT07755059
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated CirrhosisMassachusetts General HospitalNot Yet RecruitingNot Applicable
NCT07755059Not Yet Recruiting
Not Applicable
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Asci...Massachusetts General Hos...
Result Breakdown
Not yet recruiting13 (65%)
Recruiting3 (15%)
Completed3 (15%)
Enrolling by invitation1 (5%)
not_applicable12 (60%)
Phase 14 (20%)
Phase 22 (10%)
Phase 31 (5%)
Not Specified1 (5%)